PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $428,000 | +678.2% | 135,953 | +700.5% | 0.01% | +1000.0% |
| Q4 2019 | $55,000 | -86.4% | 16,983 | -90.9% | 0.00% | -87.5% |
| Q3 2019 | $404,000 | -36.1% | 186,900 | -7.1% | 0.01% | -27.3% |
| Q2 2019 | $632,000 | +348.2% | 201,247 | +314.1% | 0.01% | +175.0% |
| Q4 2018 | $141,000 | -73.7% | 48,600 | -76.2% | 0.00% | -60.0% |
| Q3 2018 | $536,000 | +857.1% | 203,900 | +969.3% | 0.01% | +900.0% |
| Q1 2018 | $56,000 | -74.0% | 19,068 | -75.7% | 0.00% | -66.7% |
| Q4 2017 | $215,000 | +102.8% | 78,394 | +151.6% | 0.00% | +200.0% |
| Q3 2017 | $106,000 | +39.5% | 31,155 | +0.8% | 0.00% | 0.0% |
| Q2 2017 | $76,000 | -71.3% | 30,900 | -61.1% | 0.00% | -75.0% |
| Q1 2016 | $265,000 | +44.8% | 79,533 | +247.3% | 0.00% | -42.9% |
| Q3 2013 | $183,000 | -2.1% | 22,900 | -5.4% | 0.01% | -30.0% |
| Q2 2013 | $187,000 | – | 24,196 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |